Literature DB >> 16014912

Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host.

Luka Cicin-Sain1, Jürgen Podlech, Martin Messerle, Matthias J Reddehase, Ulrich H Koszinowski.   

Abstract

In contrast to many other virus infections, primary cytomegalovirus (CMV) infection does not fully protect against reinfection. Accordingly, clinical data have revealed a coexistence of multiple human CMV variants/strains in individual patients. Notably, the phenomenon of multiple infection was found to correlate with increased virus load and severity of CMV disease. Although of obvious medical relevance, the mechanism underlying this correlation is unknown. A weak immune response in an individual could be responsible for a more severe disease and for multiple infections. Alternatively, synergistic contributions of variants that differ in their biological properties can lead to qualitative changes in viral fitness by direct interactions such as genetic recombination or functional complementation within coinfected host cells. We have addressed this important question paradigmatically with the murine model by differently designed combinations of two viruses employed for experimental coinfection of mice. Specifically, a murine cytomegalovirus (MCMV) mutant expressing Cre recombinase was combined for coinfection with a mutant carrying Cre-inducible green fluorescent protein gene, and attenuated mutants were combined for coinfection with wild-type virus followed by two-color in situ hybridization studies visualizing the replication of the two viruses in infected host organs. These different approaches concurred in the conclusion that coinfection of host cells is more frequent than statistically predicted and that this coinfection alters virus fitness by functional trans-complementation rather than by genetic recombination. The reported findings make a major contribution to our molecular understanding of enhanced CMV pathogenicity in the multiply infected host.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014912      PMCID: PMC1181553          DOI: 10.1128/JVI.79.15.9492-9502.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease.

Authors:  Atul Humar; Deepali Kumar; Christian Gilbert; Guy Boivin
Journal:  J Infect Dis       Date:  2003-07-29       Impact factor: 5.226

2.  Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients.

Authors:  Alain Coaquette; Alain Bourgeois; Carine Dirand; Audrey Varin; Wan Chen; Georges Herbein
Journal:  Clin Infect Dis       Date:  2004-06-23       Impact factor: 9.079

3.  Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients.

Authors:  Lisa Sarcinella; Tony Mazzulli; Barbara Willey; Atul Humar
Journal:  J Clin Virol       Date:  2002-02       Impact factor: 3.168

4.  Role of murine cytomegalovirus US22 gene family members in replication in macrophages.

Authors:  Carine Ménard; Markus Wagner; Zsolt Ruzsics; Karina Holak; Wolfram Brune; Ann E Campbell; Ulrich H Koszinowski
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection.

Authors:  D Henson; A J Strano
Journal:  Am J Pathol       Date:  1972-07       Impact factor: 4.307

6.  Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR.

Authors:  David Tarragó; Carmen Quereda; Antonio Tenorio
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease.

Authors:  Ravit Arav-Boger; Rodney E Willoughby; Robert F Pass; Jian-Chao Zong; Won-Jong Jang; Donald Alcendor; Gary S Hayward
Journal:  J Infect Dis       Date:  2002-09-30       Impact factor: 5.226

8.  Murine cytomegalovirus particle types in relation to sources of virus and pathogenicity.

Authors:  K T Chong; C A Mims
Journal:  J Gen Virol       Date:  1981-12       Impact factor: 3.891

9.  The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis.

Authors:  David Lembo; Manuela Donalisio; Anders Hofer; Maura Cornaglia; Wolfram Brune; Ulrich Koszinowski; Lars Thelander; Santo Landolfo
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus.

Authors:  Markus Wagner; Anja Gutermann; Jürgen Podlech; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  67 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severely immunodeficient host tissues but fails in exponential growth.

Authors:  Jürgen Podlech; Rares Pintea; Kai A Kropp; Annette Fink; Niels A W Lemmermann; Katja C Erlach; Elena Isern; Ana Angulo; Peter Ghazal; Matthias J Reddehase
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

Review 3.  Human cytomegalovirus intrahost evolution-a new avenue for understanding and controlling herpesvirus infections.

Authors:  Nicholas Renzette; Laura Gibson; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Curr Opin Virol       Date:  2014-08-25       Impact factor: 7.090

Review 4.  Mechanisms of genetic robustness in RNA viruses.

Authors:  Santiago F Elena; Purificación Carrasco; José-Antonio Daròs; Rafael Sanjuán
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

Review 5.  CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.

Authors:  Rafaela Holtappels; Verena Böhm; Jürgen Podlech; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2008-03-15       Impact factor: 3.402

6.  A little cooperation helps murine cytomegalovirus (MCMV) go a long way: MCMV co-infection rescues a chemokine salivary gland defect.

Authors:  Pranay Dogra; Mindy Miller-Kittrell; Elisabeth Pitt; Joseph W Jackson; Tom Masi; Courtney Copeland; Shuen Wu; William E Miller; Tim Sparer
Journal:  J Gen Virol       Date:  2016-09-13       Impact factor: 3.891

7.  Bi- and Multi-directional Gene Transfer in the Natural Populations of Polyvalent Bacteriophages, and Their Host Species Spectrum Representing Foodborne Versus Other Human and/or Animal Pathogens.

Authors:  Ekaterine Gabashvili; Saba Kobakhidze; Stylianos Koulouris; Tobin Robinson; Mamuka Kotetishvili
Journal:  Food Environ Virol       Date:  2021-01-23       Impact factor: 2.778

8.  Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2.

Authors:  Stefan Jordan; Johannes Krause; Adrian Prager; Maja Mitrovic; Stipan Jonjic; Ulrich H Koszinowski; Barbara Adler
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

9.  Competition-colonization dynamics in an RNA virus.

Authors:  Samuel Ojosnegros; Niko Beerenwinkel; Tibor Antal; Martin A Nowak; Cristina Escarmís; Esteban Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

10.  Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity.

Authors:  Adair L Borges; Jenny Y Zhang; MaryClare F Rollins; Beatriz A Osuna; Blake Wiedenheft; Joseph Bondy-Denomy
Journal:  Cell       Date:  2018-07-19       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.